Early Diagnosis and Treatment Research Foundation Inc

Analysis

Early Diagnosis and Treatment Research Foundation Inc is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in September 2009, 17 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Early Diagnosis and Treatment Research Foundation Inc reported income of $151k and spending of $264k, spending 174% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income fell from $302k to $151k (-50%), an average of -16% a year. The sharpest change came in the year to December 2022, when income rose by 257%. Over the whole period it spent 141% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Early Diagnosis and Treatment Research Foundation Inc sits at the 35th percentile: it is larger than about 35% of them. Against every charity in United States with reported income it ranks in the 47th percentile, and in the 46th percentile within NY. Charities of a similar size with the same main cause include Grant Avenue Community Center & Sacred Place Inc ($151k), Simons Angels Inc ($151k) and Cancer Research Collaboration Inc ($151k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 35% of the total. At year end it held assets of $591k against liabilities of $0, net assets of $591k.

Data notes from the register: Spending has exceeded income in each of the last three reported years, so the charity has been drawing on reserves or other funds.